The Effectiveness of Combined Naloxone/Lofexidine in Opiate Detoxification: Results from a Double-blind Randomized and Placebo-controlled Trial

REFERENCES

• Kleber H. Detoxification from narcotics. In: Lowinson J, Ruiz P, eds. Substance Abuse. Baltimore: Williams and Wilkins;1981.
   Google Scholar
• Gossop M, Gri.ths P, Bradley B, Strang J. Opiate withdrawal symptoms in response to 10-day and 21-day methadone withdrawal programmes. Br J Psychiatry. 1989;154:360–363.
   Google Scholar
• Mattick R, Hall W. Are detoxification programmes elective? Lancet. 1996;347:97–100.
   Google Scholar
• Kleber H. Treatment of drug dependence: what works? International Review of Psychiatry. 1989;1:81–99.
   Google Scholar
• Kleber H, Riordan C. The treatment of narcotic withdrawal: a historical review. JClinPsychiatry. 1982;43:30–34.
   Google Scholar
• Gold M, Pottash A, Sweeney D, Kleber H. Opiate withdrawal using clonidine: a safe, elective, and rapid non-opiate treatment. JAMA. 1980;243:343–346.
   PubMed Web of Science ®Google Scholar
• Washton A, Resnick R. Clonidine vs. methadone for opiate detoxification: double blind out-patient trials. NIDA Research Monograph No. 34. Rockville, Md: National Institute on Drug Abuse (NIDA); 1981:89–104.
   Google Scholar
• Kleber H, Riordan C, Rounsaville B, et al. Clonidine in out-patient detoxi¢cation from methadone maintenance. Arch Gen Psychiatry. 1985;42:391–394.
   PubMed Web of Science ®Google Scholar
• Bearn J, Gossop M, Strang J. Randomised double-blind comparison of lofexidine and methadone in the in-patient treatment of opiate withdrawal. Drug Alcohol Depend. 1996;43:87–89.
   PubMed Web of Science ®Google Scholar
• Kahn A, Mumford J, Rogers GA, Beckford H. Double-blind study of lofexidine and clonidine in the detoxi¢cation of opiate addicts in hospital. Drug Alcohol Depend. 1997;44:57–61.
   PubMed Web of Science ®Google Scholar
• Strang J, Bearn J, Gossop M. Lofexidine for opiate detoxi¢cation: review of recent randomised and open controlled trials. Am. J. Addict 1999;8:337–348.
   PubMed Web of Science ®Google Scholar
• Lin S-K, Strang J, Su L-W, Tsi C-J, Hu W-H. Double-blind randomized control trial of lofexidine versus clonidine in the treatment of heroin withdrawal. Drug Alcohol Depend. 1997;48:127–133.
   PubMed Web of Science ®Google Scholar
• Bearn J, Gossop M, Strang J. Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxi¢cation. Drug Alcohol Depend. 1998;50:227–232.
   PubMed Web of Science ®Google Scholar
• Buntwal N, Bearn J, Gossop M, Strang J. Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient detoxi¢cation. Drug Alcohol Depend. 2000;59:183–188.
   PubMedGoogle Scholar
• Bearn J, Bennett J, Martin T, Gossop M, Strang J. The impact of naloxone/lofexidine combination treatment compared with lofexidine monotherapy on the opiate withdrawal syndrome. Addict Biol. 2001;6:147–156.
   Google Scholar
• Resnick R, Kesternbaum R, Washton A, Poole D. Naloxone-precipitated withdrawal: a method for rapid induction onto naltrexone. Clin Pharmacol Ther. 1977;21:409–413.
   PubMed Web of Science ®Google Scholar
• Brewer C, Rezae H, Bailey C. Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using modi¢-cation of the naltrexone-clonidine technique. Br J Psychiatry. 1988;153:340–343.
   PubMed Web of Science ®Google Scholar
• Loimer N, Lenz K, Schmid R, Presslich O. Technique for greatly shortening the transition from methadone to naltrexone maintenance of patients addicted to opiates. Am J Psychiatry. 1991;148:933–935.
   PubMed Web of Science ®Google Scholar
• Loimer N, Schmid R, Presslich O, Lenz K. Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxi¢cation treatment. J Psychiatr Res. 1989;23:81–86.
   PubMed Web of Science ®Google Scholar
• Bearn J, Gossop M, Strang J. Rapid opiate detoxi¢cation treatments. Drug Alcohol Rev. 1999;18:75–81.
   Web of Science ®Google Scholar
• Riordan CE, Kleber HD. Rapid opiate detoxi¢cation with clonidine and naloxone. Lancet. 1980;1:1079–1080.
   PubMed Web of Science ®Google Scholar
• Vlissides DN, Jenner FA, Liappas IA. The use of naloxone during the withdrawal syndrome from heroin. Br J Psychiatry. 1988;152:565–567.
   PubMedGoogle Scholar
• Merrill J, Marshall R. Opioid detoxification using naloxone. Drug Alcohol Rev. 1997; 16:3–6.
   PubMed Web of Science ®Google Scholar
• Strang J, Gossop M. Comparison of linear versus inverse exponential methadone reduction curves in the detoxification of opiate addicts. Addict Behav. 1990;15:541–547.
   PubMed Web of Science ®Google Scholar
• Gossop M, Bradley B, Phillips G. An investigation of withdrawal symptoms shown by opiate addicts during and subsequent to a 21-day in-patient methadone detoxification procedure. Addict Behav. 1987;12:1–6.
   PubMed Web of Science ®Google Scholar
• Hall W, Mattick R. Is ultra-rapid opiate detoxification a viable option in the treatment of opioid dependence? CNS Drugs. 2000;14:251–255.
   Google Scholar
• Bell J, Young M, Masterman S, Morris A, Mattick R, Bammer G. A pilot study of naltrexone-accelerated detoxification in opioid dependence. Med J Aust. 1999;171:26–30.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM IV). Washington, DC: 1994.
   Google Scholar
• Woll K, Farrell M, Marsden J, et al. A review of biological indicators of illicit drug use, practical considerations, and clinical usefulness. Addiction. 1999;94:1279–1298.
   Google Scholar
• Gossop M. The development of a short opiate withdrawal scale (SOWS). Addict Behav. 1990;15:487–490.
   PubMed Web of Science ®Google Scholar
• Sheridan J, Cook CH, Strang J. Audit of the in-patient management of opioid withdrawal using lofexidine hydrochloride. J Subst Misuse. 1999;4:29–34.
   Google Scholar
• Loimer N, Aschmid R, Lenz K, Presslich O, Grunberger J. Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone. Br J Psychiatry. 1990;157:748–752.
   PubMed Web of Science ®Google Scholar
• Gossop M, Darke S, Gri.ths P, Hando J, Powis B, Hall W, Strang J. The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995;90:607–614.
   Google Scholar